Overview

A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors

Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
To assess the Safety, Tolerability, and Pharmacokinetic-pharmacodynamic Profile and efficacy of JPI-547 in patients with advanced solid tumor.
Phase:
Phase 1
Details
Lead Sponsor:
National OncoVenture
Collaborator:
Jeil Pharmaceutical Co., Ltd.